IL17A and myeloid sarcoma: In active MS lesions, increased levels of IL-17 mRNA and IL-17-related products have been detected in the astrocytes, oligodendrocytes, and lymphocytes around blood vessels; moreover, the number of IL-17 + T cells is higher in active MS lesions than in inactive lesions [45].